Catheter Precision
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Catheter Precision generated cash of -$20,619,000, which is more than the previous year. Cash used in financing activities reached the amount of $8,386,000 last year. Net change in cash is therefore -$12,294,000.
Cash Flow
| 2016 | -1.88M | -210K | 5.37M |
|---|---|---|---|
| 2017 | -5.52M | -547K | 10.38M |
| 2018 | -18.50M | -582K | 75.16M |
| 2019 | -33.17M | -16.03M | -526K |
| 2020 | -28.30M | 15.93M | 21.69M |
| 2021 | -27.62M | 3.80M | 14.96M |
| 2022 | -22.56M | 21K | 23.36M |
| 2023 | -20.61M | -61K | 8.38M |
VTAK Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.85M | 15.04M | 23.90M | 14.58M | 64.31M | 8.23M | 3.92M | 644K |
Operating activities | ||||||||
Net income | -70.57M | -26.86M | -25.07M | -36.04M | -56.95M | -30.83M | -17.76M | -4.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 2.07M | 421K | 1.56M | 2.36M | 1.75M | 624K | 218K | 95K |
Stock-based compensation expense | 1.21M | 447K | 2.23M | 4.08M | 23.54M | 0 | 12.70M | 2.3M |
| Deferred income tax benefit | 1.21M | 447K | 2.23M | 4.08M | 23.54M | 0 | 12.70M | 2.3M |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -66K | -59.19K | 42K | 368K | 251K | -1.05M | -124K | -161K |
Inventories | 8K | -14K | -197K | 352K | -2.18M | -3.87M | -644K | -181K |
Accounts payable | -550K | -879K | 627K | -961K | 407K | 699K | -47K | 124K |
Cash generated by operating activities | -20.61M | -22.56M | -27.62M | -28.30M | -33.17M | -18.50M | -5.52M | -1.88M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -36.46M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -76K | -17K | -265K | -67K | -268K | -582K | -547K | -210K |
Acquisitions Net | 15K | 38K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -61K | 21K | 3.80M | 15.93M | -16.03M | -582K | -547K | -210K |
Financing activities | ||||||||
Common Stock Issued | 8.23M | 18.90M | 15.52M | 19.88M | 37K | 78.80M | 10.43M | 5.26M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -357K | 0 | -265K | -293K | -338K | -82K | -44K | -22K |
Cash used in financing activities | 8.38M | 23.36M | 14.96M | 21.69M | -526K | 75.16M | 10.38M | 5.37M |
Net Change In Cash | -12.29M | 814K | -8.86M | 9.32M | -49.73M | 56.07M | 4.31M | 3.27M |
Cash at end of period | 3.56M | 15.85M | 15.04M | 23.90M | 14.58M | 64.31M | 8.23M | 3.92M |